Fatima Cardoso

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	67567	37339
h-endeksi	105	74
i10-endeksi	330	232

9000

4500

2250

6750

2004200520062007200820092010201120122013201420152016201720182019202020212022202320242025175 222 363 601 926 1223 1377 1472 1772 1930 2297 2677 3081 3504 3620 3920 5192 6394 7218 7584 8641 2061

Genel erişim

Tümünü görüntüle

103 makale

9 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Christos SotiriouUniversité Libre de Bruxellesbordet.be üzerinde doğrulanmış e-posta adresine sahip
E Rutgershoogleraar chirurgische oncologie UvAnki.nl üzerinde doğrulanmış e-posta adresine sahip
Giuseppe VialeUniversità di Milano e Istituto Europeo di Oncologiaieo.it üzerinde doğrulanmış e-posta adresine sahip
Christine DesmedtKU Leuvenkuleuven.be üzerinde doğrulanmış e-posta adresine sahip
Elzbieta SenkusMedical University of Gdanskgumed.edu.pl üzerinde doğrulanmış e-posta adresine sahip
Angelo Di LeoHospital of Pratouslcentro.toscana.it üzerinde doğrulanmış e-posta adresine sahip
Sherene LoiPeter MacCallum Cancer Centre, Melbourne, Australiapetermac.org üzerinde doğrulanmış e-posta adresine sahip
KONSTANTINOS TRYFONIDISMedical Oncologyeortc.be üzerinde doğrulanmış e-posta adresine sahip
Frederique Penault-LlorcaPU-PH anatomie et cytologie pathologiques, université Clermont Auvergneclermont.unicancer.fr üzerinde doğrulanmış e-posta adresine sahip
Peter A. FaschingFriedrich-Alexander Universityuk-erlangen.de üzerinde doğrulanmış e-posta adresine sahip
IT RUBIOCirujana, Universidad de Navarraunav.es üzerinde doğrulanmış e-posta adresine sahip
Carsten DenkertProfessor of Pathology, Philipps-University Marburg, Germanyuni-marburg.de üzerinde doğrulanmış e-posta adresine sahip
Mauro DelorenziSIB Swiss Institute of Bioinformaticsunil.ch üzerinde doğrulanmış e-posta adresine sahip
Rebecca DentSenior Consultant, National Cancer Center Singapore; Professor, Duke-NUS Medical Schoolduke-nus.edu.sg üzerinde doğrulanmış e-posta adresine sahip
Marc BuyseChief Scientific Officer, IDDIiddi.com üzerinde doğrulanmış e-posta adresine sahip
Sherko KümmelProfessor für Medizin, Kliniken Essen-Mitte, Wissenschaftlicher Mitarbeiter Charité Berlinkem-med.com üzerinde doğrulanmış e-posta adresine sahip
Lajos PusztaiYale School of Medicineyale.edu üzerinde doğrulanmış e-posta adresine sahip
Liyi JiaMerck Research Laboratoriesmerck.com üzerinde doğrulanmış e-posta adresine sahip
Benjamin Haibe-KainsScientist (Principal Investigator), Princess Margaret Cancer Centre, University Health Networkuhnresearch.ca üzerinde doğrulanmış e-posta adresine sahip
Suzette DelalogeInstitut Gustave Roussygustaveroussy.fr üzerinde doğrulanmış e-posta adresine sahip

Takip et

Fatima Cardoso

Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal

fundacaochampalimaud.pt üzerinde doğrulanmış e-posta adresine sahip

breast cancer guidelines new drugs


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 A Goldhirsch, EP Winer, AS Coates, RD Gelber, M Piccart-Gebhart, ... Annals of oncology 24 (9), 2206-2223, 2013	4676	2013
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up F Cardoso, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, ... Annals of oncology 30 (8), 1194-1220, 2019	2759	2019
Pembrolizumab for early triple-negative breast cancer P Schmid, J Cortes, L Pusztai, H McArthur, S Kümmel, J Bergh, C Denkert, ... New England Journal of Medicine 382 (9), 810-821, 2020	2523	2020
Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis C Sotiriou, P Wirapati, S Loi, A Harris, S Fox, J Smeds, H Nordgren, ... Journal of the National Cancer Institute 98 (4), 262-272, 2006	2386	2006
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 AS Coates, EP Winer, A Goldhirsch, RD Gelber, M Gnant, ... Annals of oncology 26 (8), 1533-1546, 2015	2376	2015
Current and future burden of breast cancer: Global statistics for 2020 and 2040 M Arnold, E Morgan, H Rumgay, A Mafra, D Singh, M Laversanne, ... The Breast 66, 15-23, 2022	2187	2022
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up E Senkus, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, ... Annals of oncology 26, v8-v30, 2015	2146	2015
70-gene signature as an aid to treatment decisions in early-stage breast cancer F Cardoso, LJ van’t Veer, J Bogaerts, L Slaets, G Viale, S Delaloge, ... New England Journal of Medicine 375 (8), 717-729, 2016	2044	2016
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer M Buyse, S Loi, L Van't Veer, G Viale, M Delorenzi, AM Glas, ... Journal of the National Cancer Institute 98 (17), 1183-1192, 2006	1551	2006
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study J Cortes, J O'Shaughnessy, D Loesch, JL Blum, LT Vahdat, K Petrakova, ... The Lancet 377 (9769), 914-923, 2011	1405	2011
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients E de Azambuja, F Cardoso, G de Castro, M Colozza, MS Mano, ... British journal of cancer 96 (10), 1504-1513, 2007	1363	2007
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 G Curigliano, HJ Burstein, EP Winer, M Gnant, P Dubsky, S Loibl, ... Annals of Oncology 28 (8), 1700-1712, 2017	1356	2017
4th ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 4) F Cardoso, E Senkus, A Costa, E Papadopoulos, M Aapro, F André, ... Annals of Oncology 29 (8), 1634-1657, 2018	1324	2018
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) F Cardoso, S Paluch-Shimon, E Senkus, G Curigliano, MS Aapro, F André, ... Annals of Oncology 31 (12), 1623-1649, 2020	1271	2020
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series C Desmedt, F Piette, S Loi, Y Wang, F Lallemand, B Haibe-Kains, G Viale, ... Clinical cancer research 13 (11), 3207-3214, 2007	1122	2007
Extracellular vesicle and particle biomarkers define multiple human cancers A Hoshino, HS Kim, L Bojmar, KE Gyan, M Cioffi, J Hernandez, ... Cell 182 (4), 1044-1061. e18, 2020	1007	2020
Event-free survival with pembrolizumab in early triple-negative breast cancer P Schmid, J Cortes, R Dent, L Pusztai, H McArthur, S Kümmel, J Bergh, ... New England Journal of Medicine 386 (6), 556-567, 2022	951	2022
3rd ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 3) F Cardoso, A Costa, E Senkus, M Aapro, F André, CH Barrios, J Bergh, ... The Breast 31, 244-259, 2017	931	2017
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) F Cardoso, A Costa, L Norton, E Senkus, M Aapro, F Andre, CH Barrios, ... The Breast 23 (5), 489-502, 2014	855	2014
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up E Senkus, S Kyriakides, F Penault-Llorca, P Poortmans, A Thompson, ... Annals of oncology 24, vi7-vi23, 2013	721	2013

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar